The system, to be established by the US Securities and Exchange Commission (SEC) and the North American Securities Administrators Association (NASAA)(1), will be based on technology used in the new Web-based Central Registration Depository (CRD) coming on line later this month.
Minivelle is currently the smallest estrogen patch available at 2.48cm 2 per patch (about 34% smaller than Vivelle-Dot). Minivelle contains bioidentical estradiol, a plant-based estrogen that is chemically identical to the estrogen produced naturally by a woman's body.
Renagel is the tablet form of sevelamer hydrochloride launched by Genzyme Corporation in 1998. Renagel has been approved by the FDA for the reduction of serum phosphorus in hemodialysis patients with end-stage renal disease. Renagel is administered in tablet form. Eligibility Renagel Medicare Part D Assistance Program, a patient assistance program provided by Genzyme Corporation, offers Renagel at no cost for up to 1 year to those who are eligible for the program.